Literature DB >> 18625952

The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.

Nicholas J Volpe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18625952     DOI： 10.1001/archopht.126.7.996

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  15 in total

1.  Simultaneous Bilateral Optic Neuritis Following Human Papillomavirus Vaccination in a Young Child.

Authors:  Ngu Dau Bing Michael; Tengku Norina Tuan Jaffar; Adil Hussein; Wan-Hazabbah Wan Hitam
Journal:  Cureus       Date:  2018-09-24

2.  Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Authors:  Grazyna Adamus; Lori Brown; Shayne Andrew; Roberto Meza-Romero; Gregory G Burrows; Arthur A Vandenbark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 3.  [Optic nerve neuritis: from an ophthalmological perspective].

Authors:  H Steffen
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

4.  [Optic nerve neuritis].

Authors:  H Steffen
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

Review 5.  Pediatric Optic Neuritis: What Is New.

Authors:  Mark Borchert; Grant T Liu; Stacy Pineles; Amy T Waldman
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

Review 6.  Atypical Optic Neuritis.

Authors:  Eric D Gaier; Katherine Boudreault; Joseph F Rizzo; Julie Falardeau; Dean M Cestari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

7.  Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mariya Dontchev; Robin L Gal; Roy W Beck
Journal:  Arch Ophthalmol       Date:  2010-03

8.  Adherence to Clinical Trial Supported Evaluation of Optic Neuritis.

Authors:  Elana Meer; Kenneth S Shindler; Yinxi Yu; Brian L VanderBeek
Journal:  Ophthalmic Epidemiol       Date:  2019-05-29       Impact factor: 1.648

Review 9.  Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Authors:  Reiko E Sakai; Daniel J Feller; Kristin M Galetta; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2011-12       Impact factor: 3.042

10.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.